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Abstract 
Introduction:Disclosure of children HIV status to HIV infected children by caregivers 
or parentsare being important medication adherence, prognosis of illness, improving 
restoration of Immunity and Psych-social well-being of coping skills. Disclosure is a 
process and not an event that takes time and constant communication in an age-
appropriate manner Human Immunodeficiency Virus- infected children live longer 
with the introduction of antiretroviral drugs. 
Objective: The aim of the study was to assess disclosure of children HIV status to 
HIV infected children by caregivers or parents and associated factors inDessie 
Referral Hospital North East, Ethiopia. 
 Methods: Institutional based cross-sectional study was conducted among 290 HIV 
infected Children caregivers or parents at Dessie Referral Hospital from March to 
May 2015; systematic random sampling technique was used to select HIV-infected 
children ages 5–14 years attending at ART clinic. Data were collected from 
questionnaires administered by clinicians to their caregivers, supplemented with 
chart review. Descriptive statistics and disclosure prevalence were calculated. 
Bivariate and multivariate logistic regression was performed to assess the 
association between disclosure and the independent variables AOR with 95% CI 
was computed.. 
Results: Prevalence of disclosure was 32.1 %( 95%CI: 27% - 38%), mean age of 
the children was 10.44 (± 2.7) years, the mean age of Disclosure was 
10.1(±1.9)years and 53.1% were Male. In multivariate regression, younger age 
(OR=0.025, 95%CI:0.005 –0.119), children Not started education (OR= 0.182, 
95%CI: 0.42– 0.798) , Non-biological caregivers (OR=4.04,(95%CI:1.573 , 10.374) ,  
caregiver-reported Adherent (OR 6.939, 95%CI 3.122 – 15.422)  and < 350 
cell/mm3 /CD4(OR = 3.221:95%CI:1.406 – 7.175) were  with HIV disclosure status. 
Conclusions and recommendation:The Prevalence of HIV status disclosure 
among children were found to be low which has been associated with their Age of 
child, Educational status of childs,CD4 count, Non-biological parents and 
Adherence. There should be regular and conceptual way of disclosure to children. 
Keywords: HIV; disclosure; children; North East Amhara, Ethiopia 
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1. Introduction 
1.1 Statement of the Problem 
In 2014 UNAIDS report 3.4 million children under the age of 15 years living with HIV 
worldwide , almost 90% live in sub-Saharan Africa(1), After the advent of the HIV 
epidemics, initially due the short survival time of prenatal infected infants and 
children, disclosure of their HIV positive status was not given close attention(2). 
Later, experience from other chronic illnesses, especially cancer was considered in 
stating that disclosure to children is beneficial to their self-esteem and will help them 
to participate in their own medical treatment. Applying the evidence-based 
knowledge being practiced within oncology to pediatric HIV disease is difficult given 
significant differences in epidemiology, the multigenerational nature of the illness, 
and the unique social stigma surrounding HIV transmission(3). 
Disclosure is the act of disclosing, uncovering or revealing; bringing to light; 
exposure(4).Disclosure is a process and not an event that takes time and constant 
communication in an age-appropriate manner(5). One of the biggest psychological 
challenges that healthcare provider and parents face is disclosure of status perinatal 
infected HIV positive children, disclosure has potential to affect a child psychological 
well-being in addition to his/her physical health in the context of chronic illness(6). 
Despite it is difficult to generalize many caregivers are reluctant for children living 
with HIV to let them to  know their status, arguing that they are too young, may not 
understand fully what is happening, may encounter emotional disturbances as a 
result, may blame their parents and ask questions on how they got the disease, and 
may inadvertently speak out the secret, exposing the family to stigma and 
discrimination(7, 8),Therefore, questions such as when to disclose, who should 
disclose, how and how much to tell, have been controversial for some time. while the 
latter stand by the child‟s right to know and participate in decision-making about 
treatment in an age-appropriate manner(9). 
The prevalence of disclosing of HIV status to infected children has been found to be 
low in different low and middle income countries (10-12). 
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The pediatrics HIV population in  Ethiopia , mostly older children who were vertically 
infected in earlier years when the coverage and effectiveness of PMTCT in the 
country was low/MTCT rates high (in 2013 163,800 HIV positive children were aged 
5-14 years)(13). In Ethiopia studies have done in Addis Ababa, Bahirdar and Gondar 
the prevalence of Disclosure is( 17.4,  35.1  and 39.5 percent) respectively for all the 
reason on non-disclosing is similar but other  factors associated with adherence 
,improving disease prognosis  and psychological outcomes did not included in their 
study of pediatrics patients to Antiretroviral therapy (ART)(12, 14, 15). 
The disclosure of HIV status to children is not yet studied in this health care facility 
and it is not known whether it may influence their clinical response to ART.  
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1.2 Literature Review 
1.2.1 Magnitude 
A different studies concerned that parents/caregivers are afraid that they will be at 
risk of depriving the child of a happy childhood(16), and will overburden the child 
with worries that are beyond its age. The reason the child is too young is given by 
caregivers in different studies in Brazil(17). AStudy conducted in Thailand28.1% 
showed that parents/caregivers felt that their child was too young(18), while the 
same was true for 57.1 percent in a study in Ethiopia(14). Though it is true that 
children may be too young to understand their disease, this needs to be discussed 
and validated with caregivers so that age-appropriate disclosure can be conducted, 
based on the child‟s level of illness understanding(19). 
Guilt: Parents/caregivers may not want to discuss because they do not have enough 
time to process the diagnosis themselves. They may still be in denial. They may also 
need to disclose a family secret about how the disease was acquired(9). Biological 
parents may be specially challenged if disclosing the child„s status means they 
automatically disclose their own (19), and so may also feel guilty for having 
transmitted the HIV virus to the child. This may result in questions from the child that 
they are not ready to answer. Studies cite cases of fear in parents that the child 
might ask how they got the disease, be angry at them for giving him HIV and act out 
these feelings.  
Fear of emotional distress  However, beyond the direct effects on children's neuron-
cognitive and psychological functioning, HIV infection may disrupt many of the social 
support systems that children depend on for optimal development(19).Study 
conducted in Ethiopia the barriers to disclosure is the fear of causing children 
emotional or psychological problems. Parents fear that the children will experience 
depression upon hearing their diagnosis and may lose their will to live nearly 43% of 
caregivers in one study stated that they fear that disclosure might have negative 
psychological consequences to the child(15). 
Stigma : study conducted identify stigma as being one of the main reasons parents 
delay disclosure, state that Caregivers identified barriers to disclosure including fear 
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of discrimination, fear of social rejection and isolation(19). Caregivers fear that the 
disclosure to the child will lead to inadvertent disclosure by him or her to others, so 
that the secret of the family will be known, leading to discrimination against the child 
and the whole family. A study carried out in South Africa showed that 73% of 
caregivers fear the child will disclose to others, and that is especially sensitive in 
large families with both HIV positive and negative members. The study states that as 
HIV infection remains highly stigmatized in south Africa  communities, disclosure of 
pediatrics HIV infection may also be accompanied by threats to the child‟s physical 
and/or psychological health(20). 
Lack of knowledge: Study conducted in Thailand many of caregiver‟s beliefs that the 
child has to be told; they felt helpless since they did not know how to do this in the 
least painful way possible. Therefore, they tended to postpone this as long as 
possible. Some even hope that the child would be able to find out about their status 
on their own (19). 
1.2.2 Factors Associated With Disclosure 
Child‟s right to know: Studies conducted in  America showed that Parents expressed 
concerns about the language of rights, which they perceived as giving too much 
liberty on children, but despite that parents also believed that children, depending on 
their age, had a right to know that the virus affected them(21) ,Another studies 
conducted in Europe, disclosure for children under six was found to be mostly 
influenced by parents perception of child needs, including the right to know, but the 
rights are not limited to knowledge of the disease, but also involve the right to 
participate in decisions with regards to their treatment(22). In another study in South 
Africa, that 98% of biological parents in  research stated that concern for the right of 
the child to know his diagnosis was their main reason for full disclosure(20) . 
Better participation regarding treatment and adherence:Disclosure of HIV status to 
HIV infected children has associated with medication adherence,  A study in Belgium 
concerning  children 0-18 years  found that some care givers reported higher 
adherence when children were aware of their HIV status(23), and also parents of 
children who refuse to take medicine or go to the clinic may wish to use disclosure 
as a means of creating better involvement by the child to all treatment, but more 
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specifically for improved adherence to ART(21).There are also instances when 
disclosure happens accidentally by parents who come up with the truth in a burst of 
anger at their child‟s unwillingness to take the drugs. Studies conducted in 
losangeles USA that disclosure of HIV status has resulted in better adherence ,while 
that the majority (58%) of children who knew their HIV status adhered well to their 
HAART regimen After a qualitative study conducted In addition to the poor 
palatability of medication and/or high pill load, two major barriers to adherence are 
children's lack of awareness of his/her HIV status and the monotony of the never-
ending treatment process(24).Other possibilities mentioned are negative reactions to 
disclosure leading to non-adherence and abstaining from taking medication due to 
fear of one‟s status being discovered by others(25). and also in Uganda study has 
conducted with 42 participants who were caregivers of HIV positive children aged 5- 
17 (median years) among those result  showed that when children where non-
disclosed  caregivers to child HIV status the child was three times less likely to 
Adhere to Highly Active Antiretroviral Therapy(26) . further studied   that if these 
factors were controlled, there was no significant association between adherence and 
disclosure (6), One other possibility is that after disclosure parents assume that 
children will take full responsibility for their medication, as in one study which found 
that prematurely releasing responsibility for ART to children results in poor 
adherence(27)Despite the general assumption that disclosure improves adherence 
by creating a better understanding by children of the need to take ART and 
enhancing trust, In Addis Ababa  multicenter institutional  studies conducted   that 
children who knew their status are less adherent or non-adherent(12). 
The difficulty in comparing these studies with those that claim better adherence with 
disclosure is due to such factors as different methodologies, sample and age 
groups. As a significant number of studies with adherence use self-report to assess 
adherence, recall bias can also be a challenge. Many being cross sectional, the 
question arises as to how it is possible to assess the time factor, and whether non-
adherence precedes disclosure or if disclosure has resulted in non-adherence. 
The following studies seem to support this argument. The first, a qualitative study 
found that disclosure was taken as a necessary step to enhance adherence, 
because children could not understand why they needed medicine while they were 
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healthy. However, an interesting finding in this study was that adherent caregivers 
who disclosed to children agreed that children were more adherent, but less 
adherent caregivers reported that non-adherent children became even more difficult 
after disclosure(23). 
A three year retrospective study on a cohort of 325 HIV-infected Romanian children 
receiving highly active antiretroviral therapy, finding significant associations between 
not knowing the HIV diagnosis and death, and not knowing the HIV diagnosis and 
disease progression defined as either death or CD4 decline that in the era of highly 
active antiretroviral therapy knowledge of one‟s own HIV infection status is 
associated with delayed HIV disease progression(28)This would need further 
research as it would increase the importance of disclosing their HIV status to 
children. 
Psychological benefits: Evidence on the emotional and psychological impact of 
disclosure was more limited. In the only study identified that quantified the 
psychological differences between disclosed and non-disclosed children,  children in 
Zambia found non-disclosed children were more than twice as likely to experience 
concerning levels of emotional difficult . In qualitative studies, many youth reported 
initial emotional difficulties, some of which were mitigated over time. In a qualitative 
study of 25 South African adolescents, almost all found disclosure to be emotionally 
difficult(29). In Brazil and the DRC, children reported feeling sadness, grief, and 
worry upon learning about their HIV infection, but these negative feelings were 
followed by some feelings of relief(17). Congolese children reported feeling calmer 
after disclosure because knowing their HIV status removed some of the uncertainty 
surrounding their illness(30). Despite the negative emotions of sadness and worry,  
A study reported that children felt that knowing HIV status was important and 
necessary(31). 
Avoidance of accidental disclosure: One factor that emphasizes the importance of 
disclosing at the appropriate time is the risk of accidental disclosure to the child 
which can happen either at home or in clinical settings. There are reports in the 
literature about parents who are tempted to disclose to their child in anger, for 
example when the child refuses to take medication. This is a less than ideal situation 
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and can be traumatic for the child who may associate the experience of disclosure 
with guilty feeling. Another possibility is for children to find out their status 
inadvertently in clinical settings(32, 33). The case of an eight year old child finding 
his diagnosis accidentally in a clinic resulted in the child‟s screaming and being very 
disturbed by the news. The problem was compounded by a mother who was not 
ready and denied to the child that he was HIV positive(27). 
Disclosure of their status to children helps to maintain their right to know and 
participate in their care, maintains their trust in their family, healthcare providers and 
community, and may improve adherence, improve progression of illness, improve 
CD4, lowering symptom of depression and stigmatization. It also provides them with 
access to support. Conversely, non-disclosure seems to have a more profoundly 
negative effect on children‟s disease progression, decline of CD4, poor adherence,   
emotional and mental status. All these factors show the importance of disclosure as 
part of HIV/AIDS care and support that need for it to be addressed routinely(32, 33). 
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Conceptual frame work 
Distal Factors                                          Proximal Factors 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Conceptual frame work for   Disclosure of HIV status to HIV infected 
children in Dessie Referral Hospital May 2015. 
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1.3Significance of the study 
According to 2014 Ethiopian MOH new ART guideline which is recommended for 
HIV infected all children less than 15 years regardless of CD4 count and WHO 
clinical stage therefore disclosure of the HIV positive status to HIV infected children 
have benefits of psychological (facilitate children's adjustment), and positive effects 
on the clinical course of the disease, increase adherence to mediationsand Improve 
diseases progression. 
Therefore  the magnitude of disclosure did not studied in this heath facility setting and 
this studywas used to determine the current magnitude of disclosure in study setting 
andalso Associated factors  including variables such as clinical indicators  , 
medication adherence, stigma  and depression which have not been including 
previous studies. 
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2 .Objectives 
2.1 General Objectives 
To assess disclosure of HIV status to HIV infected children and associated factors in 
Dessie Referral Hospital, North-East Ethiopia. 
2.2 Specific Objectives 
To estimate magnitude of Disclosure of HIV status to HIV infected children receiving 
care in DessieReferral Hospital. 
To identify factors associated with Disclosure ofHIV-status disclosure to HIV-infected 
children receiving care in Dessie Referral Hospital. 
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3. Methods and Materials 
3.1 Study Design 
Institution based cross-sectional study was conducted. 
3.2 Study Area and Periods 
The study was conducted at Dessie referral Hospital HIV care clinic from March 26 
to May 13, 2014. This hospital is found in Dessie town located in South wollo 
administrative zone, Amharic National Regional state, which is found at about 
400km Northeast of Addis Ababa (the capital city of Ethiopia) and 485km from 
Bahirdar (Amhara regional capital town) According to the 2007 population and 
housing census report, the total population size of Dessie town was estimated to be 
81, 042. This town is experiencing fast growth and according to the Dessie town 
Health office report currently Dessie town has two Public Hospital, three private 
general hospital, eight government Health Centers, five specialty clinic and more 
than seven Medium private clinics. Dessie hospital was established as a general 
hospital since 1962 dedicated to provide medical, surgical, obstetrics and 
gynecology, pediatrics and emergency service currently the hospital has a total of 
420 paid staff (291 technical and 129 administrative staff).Ithas 200 beds and it 
serves about eight million people coming from neighboring zone and region. 
The HIV care service of the Hospitals was initiated in 2005 and has three clinics: 
Adult ART clinic, Pediatric ART clinic, and VCT clinic. The clinic has one medical 
doctors providing ART services,  2 BSc. and 3 Diploma  nurses,   2 data clerks, ,1 
porter, 1 janitors,  2 case manager and 5 adherence supporters (people living with 
HIV). The Hospital uses standardized monitoring and evaluation tools and the data 
collection and management process is well controlled and supported by electronic 
data back-up and processing. Adults and Pediatrics were about 5102 and 734 who 
are taking currently on ART respectively. 
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3.3 Source and Study Population 
The source population was all children living with HIVwho ever registered to chronic 
HIV care and support program in South wollo. 
The study population was those children living with HIV who were enrolled to chronic 
HIV care and currently on follow up at Dessie Referral Hospital. 
3.4 Inclusion and Exclusion Criteria 
Inclusions:  children age between 5 -14 years old who were enrolled in chronic HIV 
care at pediatrics ART clinic ofDessie Referral Hospital was included. 
Exclusions: children who came by themselves or without caregivers. 
3.5 Sample Size and Sampling Techniques 
The sample size of the study was calculated  by usingEpi info 7 stat calculation of 
single population proportion (34) 
N= 
2
2/
2 )1(
w
Ppz 
       Where;   n= sample size: 
Observed Prevalence=39.5 proportion of HIV status Disclosure to their children  (14) 
Assumptions: 
Confidence limit =  (margin of error) = 0.04 
Z = value of standard normal distribution at 95% confidence level (z=1.96).  
n = 284 subjects 
10%non-response rate, 284 + 284 X 0.1 
  N= 312subjects 
systematic Sampling technique was used   by selecting one of the days of the week 
randomly to start andfirst were selected by follow up date from computerized 
database then Selected the first children from first day list one to two by 
lotterymethod and then was taken every other childrenuntil the desired sample size 
of 312 was reached (interval size, K = N/n = 562/312 =2) 
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3.6Variables of the Study 
Dependent variable: children HIV/AIDS disclosure status (Yes/No), 
Independent Variables: 
 Socio-demographic Characteristics 
Childs: Age, Sex, level of education, 
Care givers: Age sex, level of Education, income, residence, occupational status, 
marital status, religion. 
 caregivers level factors 
Relationship with the child (Parents or non-Parents) 
HIV and Treatment status 
Reason for disclosing and not disclosing 
Perceived advantage or disadvantage of disclosure 
Future plan to disclosure 
Preference by whom the child todisclosed, Family status (Alive/dead father, mother, 
or other family member) 
 Child health related status from child secondary data 
Age at the time of diagnosis 
Treatment status (on HAART, Anti-Tuberculosis andCo-trimoxazol) 
WHO Clinical stage (current) 
CD4 Count (current) 
Adherence status documented 
Weight (current) 
 Factors Adherence, Stigma and depression caregivers question from Questioner 
Disclosure. 
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3.7 Operational definitions 
 HIV Diagnosis disclosure:  Disclose if the caregiver were answered yes at least one 
of the questions and non-disclose if the caregivers were answered NO for all four 
questions from Questionnaire (308 - 311). 
 Adherence: Adhereif the care givers were answered No forall four questions or Non-
Adhere If the caregiver‟s wereansweredyes at least one of the question From 
Questionnaire (401 – 404). 
 Stigma: Stigmatize if the caregivers were answered yes at least one question or 
non- stigmatize if the care givers were answered No for all three question from 
questionnaire (405 – 407). 
 Depression: Depressed if the care givers were answered yes at least one question 
or Non Depressed if the caregivers were answered No for all two question from 
questionnaire(408 – 409).PHQ-2 a tool which is used easily diagnose  Depression at 
primary care setting and it took from patient  health questionnaire-9(PHQ-9)(35). 
 
3.8 Data collection tools and Data quality control 
Data wascollected by using structured questionnaire. The questionnaire 
wastranslated Amharic   to prepared then re-translated back to English to make 
reliability of the instrument, Before undertaking the data collection the instrument 
was tested taking 5% eligible for feasibility of the questionnaires and  One 
supervisor and three data collectors were participated in the data collection process. 
One day intensive training was given to the data collectors and the supervisor on 
how to conduct the data collection, data were gathered mainly through patient 
interview and revising medical records. 
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3.9Data processing and analysis 
After the data were checked for its consistency and completeness, it was entered to 
EPI- INFO version 7 then exported to SPSS version 20 for analysis. Data were 
entered by the principal investigator and cleaned before analysis.   Data result was 
presented through tables and graphs. Both bivariate and multivariate logistic 
regression model were used to identify significant variables, those Variables with p 
value<0.2 in the bivariate analysis were entered into the multivariate logistic 
regression. Ninety five percent confidence interval of odds ratio was computed and 
variable having p-value<0.05 in the multivariate logistic regression model was 
considered as significantly and independently associated with the dependent 
variable. 
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4. Ethical Considerations 
Ethical clearance was obtained from Institution review board of the Institute of Public 
Health, Collage of Medicine and Health Science, University of Gondar. Permission 
for conducting the study was secured from the Amhara regional health bureau and 
Dessie referral hospital Administration. Then written Consent/ finger print were 
obtained from all the study participants (only parents/caregivers) after they briefly 
informed about the objectives and the aim of the research. Confidentiality were 
maintained at all levels of the study by not writing the respondent‟s name on the 
questionnaire and the information weregot from the respondent not be shared for 
other persons and. Participant‟s had full write t involvement in the study were on 
voluntary basis; participants who are unwilling to respond to the questionnaire and  
those who wish to quit their participation at any stage were informed to do so without 
any restriction. All sample populations were encouraged to participate in the study. 
5. Dissemination of Results 
The result was summated as partial fulfillment of the degree of Master of Public 
Health in epidemiology and biostatistics to the institute of Public Health, College of 
Medicine and Health Sciences, University of Gondar.  
It will be also disseminated to Dessie Referral Hospital, Amhara regional Health 
bureau, South wollo Health Department and other governmental and none 
governmental organizations who are specially working on HIV/AIDS . The result will 
be also presented at University of Gondar annual research conference, and other 
conferences and workshops. Moreover, the result will be sent for publication at 
scientific National or international journals. 
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6.Results 
6.1Socio-Demography characteristics of the study caregivers/Parents 
A total of290 care givers of children respondents were included in the study with 
response rate of 93% of children age (5-14) years old on HAARTprovided 
information on the children under their care. The mean age of caregivers was 
37.8±10.6 and almost more thanhalf 56.6% of them were in the age group 30- 50 
years old. 
Above three-quarters of 87.2% caregivers were living  in urban, About  79  (27%) of 
caregivers were  attending primary education  and 151( 52.1% ) the caregivers were 
married ,Half of 51.4 % had  less than 500 birr  monthly income and 83(28.6%)   
were housewife , more than  46.9%  were  Muslim followers.  In addition, data were 
collected on the caregivers‟ sex about210(72.4 %) of the caregivers were 
Female.Approximately, three fourth 72.1%of caregivers were HIV positive, out of 
these   94.7% have been put on highly active antiretroviral therapy. Lastly, the 
majority caregivers 223(76.9 %) were biological parents (Table1).  
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Table 1: Socio-Demographic characteristics of Caretakers/parents in Dessie 
Referral Hospital, 2015 
Variables Frequency percentage 
Residence 
urban 253 87.2 
rural 37 12.8 
Age of Caregivers 
< 30 years 89 30.7 
30-50 years 164 56.5 
>50 years 37 12.8 
Sex of Caregivers 
Male 80 27.6 
Female 210 72.4 
Educational status caregivers 
No formal education 75 25.9 
Primary(1-8) 79 27.2 
Secondary(9-12) 77 26.6 
College and above 59 20.3 
Marital status 
married 151 52.1 
Single 42 14.5 
Divorced 39 13.4 
windowed 58 20.0 
Religion 
Orthodox 98 33.8 
Muslim 138 46.9 
Others 56 19.3 
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Occupational status 
Housewife 83 28.6 
Government 49 16.9 
Farmer 31 10.7 
Merchant 46 15.9 
Daily laborer 60 20.7 
others 21 7.2 
Monthly income 
<500 birr 149 51.4 
500 -1000 birr 61 21.0 
1000 – 2000 birr 30 10.3 
> 2000 birr 50 17.3 
HIV status of Caregiver 
Positive20972.1 
Negative                           8127.9 
ON HAART 
Yes                               198                                    94.7 
No                                  11                                     5.3 
Relationship with children 
Biological parents 223 76.9 
Grandparents 33 11.4 
Relatives 34 11.7 
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6.2 Socio - Demographic characteristics Children’s 
Of 290 children age 5 - 14 years old, more than half of 154(53.1%) were male. The 
mean age of the children was (10.44 years ±2.7). More than half, 65.9% children 
were between the ages (10 - 14 years old), while the rest 34.1% were between (5 - 9 
years old). The majority of the children 225(77.6%) were attending primary school. 
More than one third of the children were orphans (41%) with orphan defined as 
having a deceased biological mother, having a deceased biological father or having 
both.  Most of 76.6 % were   Biological   caregiver   of the children (Table 2). 
Table 2: Socio-Demographic characteristics of children Age of 5 to 14 years old, 
in Dessie Referral Hospital ,2015 
Variable Frequency Percentage 
Sex of child 
Male 154 53.1 
Female 136 46.9 
Age of child 
  5-9 years 99 34.1 
10-14 year 191 65.9 
Education status of child 
Not Started 23 7.9 
Kindargten 42 14.5 
Primary(1-8) 225 77.6 
Child lose any of Caregiver 
Yes 119 41.0 
No 171 59.0 
Who lose the child 
Father 45 37.8 
Mother 45 37.8 
Both mother and father 29 24.4 
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6.3 Clinical Related Characteristics of children 
Among 290 children, they had a mean age at HIV diagnosis of enrollment were 
(4.4years ± 2.5, range1-12 years) and most of 64.6% CD4 count had >500 cell/ul, 
and about 224(77.2%) were normal nutritional status.All children were on ART 
(100%).More than half of 56.2% children were taking AZT, 3TC, NVP Drug regimen 
while only 22 children (7.4%) were also taking anti-tuberculosis medication. Almost, 
77.9% wereWHOclinical stage one (Table 3). 
Table 3: Clinical and health related Characteristics of Children in 
Dessie referral Hospital, 2015. 
Variables Frequency percentage 
Age at HIV diagnosis 
< 1 years 79 27.2 
1-5 year's 115 39.7 
>6 years 96 33.1 
WHO clinical staging 
Stage I 226 77.9 
StageII&III 64 22.1 
ART Drug regimen taking 
AZT,3TC,NVP 163 56.2 
AZT,3TC,EFV 82 28.3 
others Regimen 45 15.5 
Anti-Tuberculosis Drugs 
Yes 22 7.7 
No 268 92.3 
CD4count 
<350 52 17.9 
350 -500 47 16.2 
>500 191 65.9 
Nutritional status 
underweight 66 22.8 
Normal 224 77.2 
OI prophylaxis 
Yes 245 84.5 
No 45 15.5 
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6.4 Behavioral and Psychological characteristics of HIV infected children 
reported by caregivers 
According to Caregiver- self reported adherence (69%) and (31%)were  Adherent 
and  Non-adherent  respectively . Experienced stigma (7.2%) and (92.8%) were 
reported stigmatized and Non-stigmatized respectively and   child depression 
symptoms (19.3%) and (80.7%) were reported depressed and Non-depressed 
respectively (Table 4). 
Table 4: Behavioral and Psychological characteristics of HIV infected children 
reported by caregivers, Dessie referral hospital, 2015. 
 
Variable 
 
 
Frequency 
 
 
Percent 
Adherence status  
Adherent 
        Not Adherent 
 
200 
90 
 
69.0 
31.0 
Stigmatized reported  
 Not Stigmatized 
          stigmatized 
 
269 
21 
 
92.8 
  7.2 
Depression reported 
Not  Depressed 
          Depressed  
 
234 
56 
 
80.7 
19.3 
 
 
 
 
6.5Magnitude of HIV-Positive Status Disclosure to HIV infected children. 
The prevalence of Disclosure of the children living with HIV 32.1 %( 95% CI: 27%, 
38%) were disclosed HIV status to infected children by their caregivers/parents. 
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Themean age at disclosure was 10.1 years (±1.9years). More than half of 
children54.8%were disclosed by their Biological parents while 26.9 of children were 
disclosed by others (Healthcare provider, friends and neighbors) and Forty-eight 
(48.4%) of the disclosers were HIV-positive caregivers.  
The prominent reasons for disclosure as mentioned by caregivers were “child 
refused medication (35.5%), repeated question asked “what happened to me” 
(27.9%), child thought to be matured” (22.6%) and Heard from friends and 
neighbors” (14%) (Figure 2). 
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Figure 2: Reasons for Disclosing HIV Status to HIV infected Children by 
caregivers replied In Dessie Referral Hospital, 2015. 
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Caregivers/parents Replied that the reason for not disclosed HIV status to HIV 
Infected children 
Parents/caregivers mentioned reasons for not disclosing to their child about his/her 
HIV positive status. More than one third (36%) still believedthat fear of self-
discrimination; A quarter (25%) believed that the child is too young and another 
reasons about17.3 %,11.2% and 10.7%they believed that  fear of negative 
emotional and health consequence,  lack of Knowledge  fordisclosure  and child may 
not keep secret respectively (Figure 3). 
 
 
Figure 3: Reasons for not disclosingHIV Status to HIV infected Children by 
caregivers replied In Dessie Referral Hospital, 2015 
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Those caregivers did not disclose their child HIV status Beliefs, Future plan and 
preference to disclose HIV status to HIV infected children by caregivers, in Dessie   
Referral Hospital March 26 to May 13 2015. 
Of the children who didn‟t know their HIV positive status, More than half 52.3%were 
reportedly child ever has asked why take medicine.  About 177(89.8%) care givers 
replied they believed that advantage of disclosure to HIV infected children‟s.    
Almost 92% replied regarding future plan to be disclosed for their HIV infected 
children.   Caregivers were also asked about the person who should be   responsible 
for disclosure of HIV status to children and about  96 (48.7%) caregivers with the 
help of health care provider,41(20.8%) of them replied by caregiver and 60 (30.5%) 
by caregivers/parents (myself). Caregivers perceived that in what condition of 
disclosure happened  More than three-fourth   of care givers ( 85.% )mentioned that 
children have to be disclosed when feel healthy and only30 (15.2%)  replied that   
disclosure to be done when  at any health condition ( when sick or healthy.) 
6.6Factors Associated with HIV Positive Status Disclosure to HIV infected 
children 
In the multivariate logistic regression age of the child, educationalstatus 
ofchild,caregivers relation to the child, CD4 count and Adherence reported were 
independently and significantly associated with disclosure of HIV-positive status to 
HIV infected children. However, factors related to the caregiver such as Age of care 
giver, marital status,  HIV-positive status, and educational status, as well as Age at 
HIV diagnosis, ART regimen , and child lose any caregiver  were not significantly 
associated with disclosure of HIV-positive status to HIV-infected children. 
Accordingly, non-biological parents were 4.04 (AOR =4.04, 95% CI: 1.573, 10.374) 
times more likely to disclose HIV-status to HIV-infected children as compared to 
biological ones,CD4 count  < 350 cell/um were 3.221(AOR=1.406 , 7.175) times 
more likely  to disclose HIV status to HIV infected children  as compare to  > 500 
CD4 count , Caregiver reported  adherent were   6.939(AOR=6.939,95%CI:3.122 – 
15.422) times more likely to disclosed HIV status to HIV infected children as 
compared  to non-adherent children.  Age of the child was one of the factors 
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significantly associated with disclosure ofHIVstatus in which children younger than10 
years of age were 0.025(AOR = 0.025, 95% CI: 0.005, 0.119) times lesslikely to be 
disclosed as compared their counterparts. 
Those children who not schooling were 0.182(AOR = 0.182, 95% CI: 0.42, 0.798) 
times less likely to be disclosed their HIV-p status as compared to   attending 
Primary education (Table 4). 
Table 5: Bivariate and multivariate analysis of factors associated with 
disclosure of HIV status to HIV-infected children in Dessie Referral 
Hospital, Northeast Ethiopia, 2015. 
Variables Disclosure status COR(95%CI)  AOR(95%CI)  
Not Disclosed Disclosed 
Age of caregiver 
<30 years 64(32.5) 25(20.9) 1    
30 - 50 years 116(58.9) 48(51.6) 1.059(.598- 1.876)    
> 50 years 17(8.6) 20(21.5) 3.012(1.36 -6.668)    
Marital Status 
   Married 110(55.8) 41(44.1) 1 
   Single 25(12.7) 17(18.3) 1.824(.894 ,3.722) 
   Divorced 29(14.7) 10(10.8) 0.925(.414 ,2.07)) 
   Windowed 33(16.8) 25(26.9) 2.033(1.081, 3.822) 
   Educational  status of caregivers 
   No formal Education 50(24.9) 25(20.9) 2.315(1.030 -5.203) 
   Primary(1-8) 48(24.4) 31(33.3) 2.82(1.272-6.245) 
   Secondary(9-120 52(26.4) 25(26.9) 2.1(0.933-4.718) 
   College and above 48(24.4) 11(11.8) 1 
   HIV status of Caregiver 
   Positive 151(76.6) 58(62.4) 1 
   Negative 46(23.4) 35(37.6) 1.981(1.162- 3.378) 
   Age of children 
   5-9years 87(44.2) 12(12.9) 0.187(0.096 - 0.37) 
 
0.025(.005-0.119) 
 10-14 years 110(55.8) 81(87.1) 1 
 
1 
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Educational  child 
Not started 10(5.1) 13(14.0) 0.24(0.08-0.714) 
 
0.182(0.42- 0.8) 
 Kindargten 32(16.2) 10(10.8) 0.35(0.145, 0.83) 
 
0.03(0.005 – 0.19) 
 Primary(1-8) 155(78.7) 70(75.3) 1 
 
1 
 Relationship for children 
   Biological Parents 163(82.7) 60(64.5) 1 
 
1 
 Grand parents 14(7.1) 19(20.4) 3.687(1.74,7.814) 
 
4.040(1.573 - 10.374) 
Relatives 20(0.2) 14(15.1) 1.902(.903,4.003) 
 
1.64(.659 - 4.105) 
 Child Lose anycaregivers 
   Yes 70(35.5) 49(52.7) 2.02(1.224-3.224) 
   No 127(64.5) 44(47.3) 1 
   CD4 count 
   <350 25(12.7) 27(29.0) 3.13(1.661-5.897) 
 
3.22(1.41-7.18) 
 350 -500 30(15.2) 17(18.3) 1.642(.834 - 3.234) 
 
2.36(1.019 -5.44) 
 >500 142(72.1) 49(52.7) 1 
   Age at HIV diagnosis 
   <1years 68(34.5) 11(11.8) 1 
   1-5 years 77(39.1) 38(40.9) 3.051(1.447,6.433) 
   > 6 years 52(26.4) 44(47.3) 5.231(2.464 -11.11) 
   Child ART drugregimen 
      AZT,3TC,NVP 118(59.9) 45(48.4) 1 
   AZT,3TC,EFV 46(23.4) 36(38.7) 2.052(1.178 - 3.58) 
   Others regimen 33(16.8) 12(12.9) 0.954(0.453-2.01) 
   Adherence reported 
      Adherent 117(59.4) 83(89.2) 5.68(2.776 -11.60) 
 
6.939(3.122,15.242) 
 Non-Adherent 80(40.3) 10(10.8) 1 
 
1 
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7.Discussion 
As children with HIV survive into adolescence and adulthood at unprecedented 
rates, disclosure of HIV status is an essential component of pediatric HIV care and 
long-term disease management. This study determined the prevalence and 
Associated factors  of  HIV status disclosure  to HIV infected children‟s who had 
receiving HAART among caregivers of children aged 5 - 14 years in  Dessie referral 
hospital  pediatric ART clinics, Dessie , North East Ethiopia. This study found a 
minority of children aged 5–14 years32.1 (95%CI: 27% - 38%) knew HIV status, 
consistent with findings from studies in Thailand (30.1%)(19)and previous study in  
Bahirdar and  Gondar ,Ethiopia (31.5%and 39.5%) and   which found  231 and 428 
children with a median age of 9.8(SD=2.6) and 9.96(SD=3)respectively (14, 15).but  
lower than the findings reported in California (USA) (43.1%)(28)  The high level of 
disclosure in United States may be due to socio-cultural differences showing higher 
levels of expressiveness within the family and more intensive child-parent 
interactions which is not the case in most African countries, including Ethiopia. 
The lower prevalence of disclosure in this study as compared to developed countries 
might be due to caregivers‟ thought child too young ,fear of stigma and 
discrimination and believed that their children would be isolated by their friends at 
school and in the community, and fear of negative consequences for the child. 
Caregivers were also lack knowledge and skills on how to approach/inform their HIV 
infected children about their HIV diagnosis in this study. On the other hand, in 
developed countries such as the USA, there are guidelines for disclosure of HIV 
positive status to children developed by the American Academy of 
Pediatrics(9),which contains detailed instructions on the process of disclosure but 
such guidelines do not exist in Ethiopia, although there was  an effort of include 
issues related to disclosure in the  new consolidated „„Guidelines for Pediatric 
HIV/AIDS Care in Ethiopia‟‟ developed by the Federal HIV/AIDS Prevention and 
Control Office and Federal Ministry of Health in 2014(36). 
However, the disclosure rate of children‟s HIV positive caregivers Asked about the 
person who should be the person responsible for disclosure of HIV status to children 
in this study, about 48% of them replied health caregivers with the help of healthcare 
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provider and 30% by caregiver or family. This result is  little bit  different with the 
study conducted in Addis Ababa, Ethiopia 60% believed that the doctor should be 
responsible(12), and in South Africa 55% who thought that the biological mother 
should be the one to disclose the HIV diagnosis to the child(37). 
Age of child was found to be a significantly associated with disclosure of HIV positive 
status, children (6-9) years of age were 0.025  times  less  likely to be 
disclosed/informed of their HIV positive status as compared to their counterparts 
(AOR = 0.025 [95% CI = 0.005,0.119]). This result is consistent with the finding from 
others studies (14, 15, 37)and this showed that younger age of infected children as a 
determinant factor for HIV positive status disclosure. Likewise it is congruent with the 
study conducted in South Africa which showed the mean age at disclosure was 10.1 
years (37) which was comparable with in the current study (9.8 years). The 
educational status of child was found to be significant associated factors ofHIV 
status disclosure, children not started education were 0.182 times less likely to be 
disclosed HIV status as compared primary education.The study is consistent  in sub-
seharan Africa and North Indian(38-40). It might be related to younger age of 
childrenand not attending school was lesslikely to hear regarding theHIV status than 
their counter parts. 
In this study, when children currently live with non-biological caregivers were more 
likely to disclose the child‟s HIV-positive status than biological caregivers. This 
finding is in agreement with studies done in Ethiopia, Philadelphia and Thailand (14, 
18, 41) where most children who knew their diagnosis were living with caregivers 
who were not their  biological  parents , whereas the majority of children who did not 
know the diagnosis were living with biological parents. As argued by these studies 
biological parents might not be willing to confront the fact of their own responsibilities 
in passing the infection onto their children. 
In this study< 350 CD4 cell/mm3 more likely associated to disclose HIV status as 
compare to >500 CD4cell/mm3 ,it is consistent to a study Thai found that while 
disclosure was associated with  CD4 below 30%(42). 
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In contrast, a study in Romania found that children who did not know their HIV status 
were at higher risk for disease progression, measured by CD4 count decline and 
death compared to disclosed children.(28) 
It is found thatstrong association with care givers reported who had adherent 
childrenwere more likely to disclosed HIVstatus than caregiver self-reported   non - 
adherent.  Disclosure is a traumatic event for many children and can be 
accompanied by feelings of anger, hopelessness and rebellion, which may lead to 
temporary or longer-term adherence problems. Adherence issues may be 
compounded by other specific factors such as increased incidence of 
depression(43)and generally poorer medication adherence among this age 
group(43, 44).  On the other hand, there are also reasons to believe disclosure may 
lead to improved adherence, including increased responsibility over medication-
taking and better access to social support. Pediatric HIV providers often recommend 
disclosure of HIV status to children as necessary to building trusting provider-patient 
and family relationships and developing disease management skills that facilitate 
adherence.(44) In USA only longitudinal study to assess adherence pre- and post-
disclosure, reported that approximately 58% of children and their caregivers reported 
that adherence improved post-disclosure(24). 
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8. Limitation 
Self-reports information on adherence, and experiences of stigma and depression 
May not be enough to be used. 
The cross-sectional design of this study did not allow us to measure causal 
pathways of disclosure or the potential impact of disclosure on Adherence and CD4 
count. 
9 .Conclusions 
The magnitude  of disclosure of HIV positive status to HIV infected children was 
found to be low and Children  younger  than 10 years of age, Children Educational 
status, Non-biological caregivers, and caregivers reported adherent and 
<350CD4cell/mm3 were significantly associated with disclosure of HIV positive 
status to HIV infected children . 
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10 Recommendation 
 Health care provider 
Improving and focusing counseling services for caregivers through professionally 
skilled counselors are important for timely disclosures. 
It is important to improve child adherence to disclose their HIV status timely. 
Health professional should be discussing the HIV status of children at their 
appointment date and should give focus for non- schooling children to disclose at 
appropriate time. 
Caregivers of children 
Biological parents have to disclose to their HIV status to HIV infected children at 
appropriate time. 
They should be encourage children to ask question, do not be disappointed if they 
do not react in the manner you expected. 
MOH/RHB 
Existing materials on disclosure should be made available for adaptation, evaluation 
and broader implementation. 
Researcher 
Prospective study on disclosure of HIV status in this setting are needed to answer 
these important questions as more HIV-infected children and adolescents make the 
difficult transition to adulthood. 
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12: Annexes  
Annex I: English Information Sheet 
Introduction 
This information sheet is prepared to explain the research project that you are asked 
to join by a group of research investigators. The main aim of the study is to assess 
Disclosure of   HIV status to HIV infected children   and associated factors in Dessie 
Referral Hospital. 
The research team includes a final year MPH graduate student, one health officer; 
three ART trained nurses from Dessie Referral Hospital. 
Name of Principal Investigator: ShimelsNegash 
Name of Advisors: Mr. Kefyalew Addis   and Mr. DigsuNegesse 
Name of the Sponsor: 
Name of Organization: University of Gondar, Institute Public Health College of 
Medicine and Health Science 
This information sheet is prepared by above mentioned researcher whom main aim 
is to assess Disclosure of   HIV status to HIV infected children and associated 
factors in Dessie referral Hospital North East, Amhara Region Ethiopia, and 2015. 
The investigator is a final year MPH student with his advisors from Institute of public 
health, college of medicine and health sciences, university of Gondar. 
Purpose: The purpose of this research study is toassess Disclosure of   HIV status 
to HIV infected children   and associated factors in Dessie referral Hospital. North 
East, Amhara Region, Ethiopia, Results from this study will be used to assist in 
decision making and planning for improving, preparing   of health care providerto be 
given attention ongoing counseling and advocating the importance of disclosure of 
HIV status to infected children. 
Procedure: This study uses institution based quantitative cross-sectional study 
design, through using interview with standard structured Questionnaire and 
Permission will be processed from the University of Gondar and medical director of 
Dessie referral hospital. 
Risk and/or Discomfort: There is no any risk or discomfort that you will face by 
participating in this research except dedication of time for responding the questions. 
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Any personal will be kept confidentially. There is no any risk in participating in this 
research project. 
Benefits: There will be benefit for Dessie Referral Hospital, Dessietown woreda 
administration, Zonal health desk, Amhara regional health Bureau and stake holders 
who work in Pediatrics and HIV and as well for the participants. The findings of the 
study are no doubt to implement the intervention. 
Incentives/Payment for Participating: There is no incentive or payment to be 
gained by taking part in this project. 
Confidentiality: All Personal identification& personal information will not be taken 
that is anonymous. The information collected from this research project will be kept 
confidential. Information will be accessed by the researcher and research assistant 
only. 
Persons to contact: This research project will be reviewed and approved by the 
ethical committee of the University of Gondar. If you want to know more information 
you can contact the committee through the address below. If you have any question 
you may contact the following individuals. 
Investigator:+251911558363,Email:shimels_1@yahoo.co 
Advisors: 1. +251920256699, E-mail: kefadis@gmail.com 
2. +61469738236, E-mails: digsuneg@gmail.com 
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Annex II:የአማርኛየመረጀዉሌቅጽ 
የምርምርፕሮጄክቱርዕስ  - 
በዯሴሆስፒታሌወሊጆቻቸዉወይምአሳዲጊዎቻቸዉየኤች.አይ.ቪቫይረስሊሇባቸዉህጻናትስሇማሳወቅከማሳወቅምጋርተያያ
ዥነትያሇቸዉንጉዲዮቸማጥናት 
የዋናተመራማሪዉስም- ሽመሌስነጋሽ 
የዴርጅቱስም፡በጏንዯርዩኒቨርሲቲህክምናናጤናሳይንስኯላጅየህብረተሰብጤናአጠባበቅኢንስቲትዩት 
ወጭዉንየሚሸፍነዉአካሌ፡- 
መግቢያ፡-
ይህመረጃናስምምነትየተዘጋጀበትዋናአሊማበምርምርፕሮጀክቱየሚሳተፉየምርምርፕሮጄክቱአባሊትስሇፕሮጀክቱእንዴያብ
ራሩበትታስቦነዉ፡፡የጥናቱቡዴንምሦስትዴግሪያሊቸዉንነርሶች፣አንዴዴግሪያሇዉንተቆጣጣሪናሁሇትአማካሪዎችንከጏንዯር
ዩኒቨርሲቲያከተተነዉ፡፡ 
ጥናቱየሚካሄዴበትምክንያት:-
የፕሮጀክቱዋናአሊማምንያህለቫይረሱበዯማቸዉየሚገኝህጻናትስሇራሳቸዉበወሊጆቻቸዉወይምበተንከባካቢዎቻቸዉእንዯ
ተነገራቸዉ ና 
ስሇበሽታዉከመንገሩሂዯትጋርተያያዠነትያሊቸዉንጉዲዮችማጥናትናማወቅሲሆንበተጫማሪምበጥናትሊይየተመሠረተየጤና
ፖሉሲሇማዉጣትእንዯምያግዝየታመነበትነዉ፡ 
አተገባበር: በዯሴሆስፒታሌየሚገኙየኤች.አይ.ቪቫይረስበዯማቸውውስጥያሇየኤች.አይ.ቪህክምናአገሌግልትተጠቃሚ 
ህጻናትንሰሇረራሳቸዉጤንነትሁኔታማሳወቅበተዘጋጀዉጥናትዴርሻእንዴኖሪዎጋብዘነዎታሌ፡፡በፕሮጄክቱሇመሳተፍፈቀዳኛ
ከሆኑሉፈርሙይገባሌ፡፡ከዚያምበመረጃሰብሳቢዎችምሊሽዎንእንዴሰጡይጠየቃለ፡፡በዚህጥናትእንዴሳተፉየተመረጡትበና
ሙናአወሳሰዴስሌትነዉ፡፡የሚሰጡትመረጀበአጠቃሇይናየጥናቱዉጤትበተናጠሌማንምበማያገኛዉመሌኩበመሇያቁጥርሚ
ስጢራዊነቱየተጠበቀይሆናሌ፡፡ 
ሉገጥምየምችሌችግርወይምአሇመመቸት፡-
በዚህጥናትበመሳተፍዎምንምአይነትየሚዯርስብዎችግርየሇም፡፡መጠይቁንሇመሙሊትየተወሰነሰአት(15-20ዯቂቃ) 
ሉወስዴበዎይችሊሌነገርግንይህጥናትሇወዯፊቱሇሌጅዎሇዕርስዎናሇህብረተሰቡካሇውጥቅምአኳያይህብዙአይዯሇም:፡ስሇዚህ
የእርስዎመሌስክፍተቱንሇማሳየትናሇማሻሻሌጠቃሚግብዓትነዉ:፡ 
ጥቅሞች፡- 
በዚህምርምርስሊተሳተፉሇእርስዎበቀጥታወይምበተዘዋዋሪጥቅምይኖረዎታሌ፡፡ምክንያቱምጥናቱየኤች.አይ.ቪቫይረስበዯማ
ቸውውስጥያሇየኤች.አይ.ቪህክምናአገሌግልትተጠቃሚ 
ህጻናትስሇበሽታቸዉማሳወቅሂዯትናጠቀሜታሇማሻሻሌያሇመበመሆኑእርስዎናቤተሰብዎየአገሌግልቱተጠቃሚይሆናለና፡፡ 
ሇመሳተፍጥቅማጥቅም/ክፍያ: በዚህጥናትበመሳተፍዎምንምክፍያአይሰጥዎትም፡፡ 
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ሚስጢራዊነት፡ከዚህምርምርፕሮጀክትየተሰበሰበመረጀምስጢራዊይሆናሌ፣ስሇእርስዎየተሰበሰቡትመረጃዎችስምዎሳይጸፍ
በትበሚስጥርይያዛሌይህምከዋናተመራመሪዉበስተቀርማንምእዲያዉቀዉያዯርጋሌ፡፡ 
ዕንቢየማሇትወይምየማቋረጥመብት፡በዚህምርምርየመሳተፍምሆነያሇመሳተፍሙለመብትአልት፡፡ጥያቄዎቹንሙለምሆነበ
ከፊሌመሌስአሇመስጠትይችሊለ፡፡ይህዯግሞማንኛዉንምየጤናአገሌግልትከማገኛትአያግዴወትም፡፡እንዴሁምበማንኛዉም
በፈሇጉሰዓትያሇምንምመቀጮየማቋረጥሙለመብትአሇዎት::ሉያገኙአቸዉየሚችለአቸዉሰዎች:-
ይህየምርምርፕሮጀክትበጏንዯርዩኒቨርሲቲየጥናትናምርምርስነምግባርኮሚቴተከሌሶይጸዴቃሌ::ተጨማሪመረጃማወቅከፈ
ሇጉየኮሚቴዉንአባሊትከዚህበታችባሊዉአዴራሻማግነትይችሊለ፡፡ጥያቄከሇዎትከሚከተለትግሇሰቦችማናቸዉንምበፈሇጉሰ
ዓትመጠየቅይችሊለ፡፡ 
 አቶሽመሌስነጋሽ ፡ 
 አቶከፍያሇዉአዱስ፡በጏንዯርዩኒቨርሲቲህክምናናጤናሳይንስኯላጅየህብረተሰብጤናአጠባበቅትምህርትቤትስሌክ+2519
20256699  ኢ ሜሌ፡kefadis@gmail.com 
 አቶዴግሱነገሰ  ፡ በጏንዯርዩኒቨርሲቲህክምናናጤናሳይንስኯላጅየህብረተሰብጤናአጠባበቅትምህርትቤትስሌክ 
+251920256699  ኢ ሜሌ፡digsuneg@gmail.com 
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AnnexIII: English Consent Form (Certificate) 
A questionnaire prepared by university of Gondar Medical and Health Sciences 
Institute of Public Health On Assessment Of Disclosure HIV Status To HIV Infected 
Children And Associated Factors in Dessie Referral Hospital ART Clinic. 
Introduction: 
My name is …………………………….., I am working in Dessie Hospital, I am 
interviewing Caregivers/parents who has child on ART Follow up  in this hospital. 
The purpose of this questionnaire is to gather information to find out   the rate of 
Disclosure practice among parents/caregivers and associated factors with HIV 
status disclosure to your child .after the study is completed the result will be given for 
responsible bodies to act accordingly and improve the service. I will ask you some 
questions which will take 15-25 minutes. The answer to those questions is 
confidential. I will not write your name in the questionnaire. You can refuse and 
interrupt to respond to any of the questions. There is no harm or cost to participate in 
the study.So I kindly request your cooperation and time for this short interview 
session. if you are willing to participate ,please give your written or finger print 
consent for the one who will interview you . 
Thank you 
Would you participate in responding to the questions in this questionnaire? 
Yes___No______ 
NameandSignature/finger print of the participants___________________________ 
Name and Signature of the data collector _________________________________ 
Name of Investigator: ShimelsNegash 
Address of the investigator: 0911558363, Gondar, Ethiopia 
Questionnaire No___________ 
Interviewee Code_____________ 
Date of Interview_______________ 
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Annex IV: English Version Questionnaire 
Instructions: 
Fill in the blank space. 
Circle the appropriate answer. 
Do not omit any item of information 
1,Question related to Socio-Demographic characteristics of parent’s/caregivers 
NO Question Response category Code 
101 Place of residence 1,Urban 
2,Rural 
 
102 Sex of care givers 1,Male 
2,Female 
 
103 How old are you? ____________________.(in years)  
105 Religion 1,Orthodox 
2.Muslim 
3,Catholic 
4,Protestant 
5, Others (Specify)……………………. 
 
106 Which education level do you accomplish? 1,Can‟t  read and write 
2,Read and write only 
3,Primary school(1-8) 
4,Secondary school(9-12) 
5,College  and above 
 
107 What is your occupation? 1,Housewives 
2,Government employee 
3,Farmer 
4,Merchant 
5,Daily laborer 
6,Others(specify) 
 
108 What is your Marital status? 1,Married 
2,Single 
3,Divorced/ 
4,Windowed 
5,Separate 
 
109 What is your monthly in come? ________________________in Birr.  
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2,Socio-Demographic characteristics of the child 
201 Sex 1,Male 
2,Female 
 
202 Age ______________________(in years)  
203 Which educational levels do your child 
attended? 
1,Not started Education 
2,Kindargten 
3,Primary(1-8) 
4,Secondary(9-12) 
 
3. Questions for the care giver/parent 
301 Have you ever been tested for HIV? 1,Yes 
2,No 
If2>Q305 
302 Would you like tell me your (the caregivers) HIV 
status? 
1,Yes 
2,NO 
If 2 >Q305 
303 IF Yes, What is your HIV status? 1,Positive 
2,Negative 
 
304 If positive, are you on HAART? 1,Yes 
2,No 
 
305 Does the child lose any of his/her parents due to 
HIV? 
1,Yes 
2,No 
IF2  >  
Q307 
306 If yes, lost who? 
(Multiple response is possible) 
1,Mother 
2,Father 
3,Both mother and father 
4,Other family member/sibling 
 
307 What is your relationship with the children? 1, Biological Parents 
2,Grand Parents 
3,Orphanage 
 
308 Does the child know that‟s/he comes to the clinic 
for HIV care? 
1,Yes 
2,No 
 
309 Does the child know that the name of his/her 
illness? 
1,Yes 
2,No 
 
310 Does the child know that s/he is taking medicine 
for HIV? 
1,Yes 
2,No 
 
311 Does the child know that s/he has HIV? 1,Yes 
2,No 
IF2 the
Q316 
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312 If yes at least one Q308 -3011 
Who has disclosed that information? 
1,Biological parents 
2,Grand Parents 
3,Otherfamily Members 
4,Health care providers 
5,Others 
(Specify)__________________ 
 
313 What is the HIV status the one who Disclosed? 1,Positive 
2,Negative 
3,Don‟t Known 
4, Do notwilling to tell 
 
314 How old was when s/he is told her/his HIV 
status? 
 
______________________ in 
years 
 
315 What was the reason for disclosure? 1,The child thought to be matured 
2,Child refused to take 
medication/to go clinic on 
appointment date 
3,S/he heard the diagnosis from 
friends /Neighbors 
4,Repeated question by the child 
what happened to him/her 
5,othersreason(Specify)_________ 
 
316 (IF No Q No 307) 
IF not disclosed about the disclosure status 
what is the reason for not disclosing the child 
HIV status to their child itself? 
 
1,Child is too young 
2,Fear of Negative emotional and 
Health consequence 
3,Because of S/he can not kept 
secret 
4,The child can not understand 
5,Don not know the advantage of 
telling(Disclosing) 
6,Fear of Child Discrimination 
7,Others(Specify)______________ 
 
317 Dose the child ever ask question about why s/he 
has taken medicine? 
1,Yes 
2,No 
 
318 Do you think that Disclosing the HIV diagnosis 1,Yes  
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to an infected child has advantage? 2,No 
3,I don‟t Know 
319 Do you have an intention to Disclosed the HIV 
Diagnosis to the child in the future? 
1,Yes 
2,No 
 
320 IF Yes Q No 320 
How would you want to disclose HIV diagnosis 
to the child? 
1,To disclose  by myself 
2,To disclose by a health care 
providers 
3,To disclose by myself, but with 
the help of care providers 
 
321 When do you think a child should be disclosed 
for his/her HIV status ? 
1,At any time 
2,When Sick 
3,When Relatively health 
 
4,Questionarie related Adherence stigma and Depression items 
401 Dose the child ever refuse to take medicine s/he 
is supposed to take? 
1,Yes 
2,No 
 
402 Do you ever not give the medicine because you 
do not want to give them in front of another 
people? 
1,Yes 
2,No 
 
403 Do you ever have problems with giving the 
medicine because the child does not know why 
s/he is taking them? 
1,Yes 
2,No 
 
404 Does the child ever have problems taking the 
medicine on time or taking them every day? 
1,Yes 
2,No 
 
405 Do other children avoid plying with the child 
because of her/his HIV status? 
1,Yes 
2,No 
 
 
406 Do other children tease or call the child names 
because of her/his HIV status? 
1,Yes 
2,No 
 
 
407 Has your child been rejected by friends or family 
because of her/his HIV status? 
1,Yes 
2,No 
 
 
408 Does your child seem to have little interest or 
pleasure in doing things lately? 
1,Yes 
2,No 
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409 Has your child been feeling down, depressed or 
hopeless? 
1,Yes 
2,No 
 
 
5. secondary data Clinical markers of HIV infected children from ART record 
501 Age at diagnosis of HIV _____________________in years  
502 What is the current WHO clinical Stage? 1,T-Staging I 
2,T-Staging II 
3,T-StagingIII 
4,T-Staging IV 
 
503 What is the child current CD4 count? _________________________  
504 What is the child taking ARTregimen? _________________________  
505 What is the child weight current? _________________________(Kg)  
506 Dose the child has currently on Anti TB? 1,Yes 
2,No 
 
507 Dose the child has currently taking Co-
trimoxzol? 
1,Yes 
2,No 
 
 
Thank you for your responses! 
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Annex V: አማርኛየፈቃዯኝትመጠይቂያቅጽ 
በጎንዯርዩኒቨርሲቲ፣በህክምናእናጤናሳይንስኮላጅየህብረተሰብጤናአጠባበቅኢንስቲትዩትሰሇኤችአይቪሁኔታሇራሳቸዉቨ
ይረሱበዯማቸዉሊሇባቸዉሌጆችበወሊጆቻቸዉ/በተንከባካቢዎቻቸዉመንገርወይምማሳወቅናከማሳወቅጋርተያያዥነትያሊቸ
ዉንጉዲዮችአስመሌክቶየተዘጋጀመጠይቅ 
መግቢያ፤ 
ጤናይጥሌኝ፣ሰሜ______________________________________ይባሊሌ፣ዯሴሆሰፒታሌዉስጥነዉየ
ምሰራዉ፡አሁንበዚህሆስፒታሌውስትየህከምናከትትሌሇሚያረጉሌጆችሊሊቸዉአሳዲጊዎችናዎሊጆችመጠይቄንአቀርባሇሁ፡፡
ከዚህበመቀጠሌሇማካሄዴስሊሰብኩትጥናትገሇጻአዯረግሌዎታሇሁ፡ይህጥናትየሚያተኩረዉበዯማቸዉየኤችአይቪቫየረስሊሇ
ባቸዉሌጆችሰሇማሳወቅሲሆንአሊማዉሀ/ምንያህለቫይረሱበዯማቸዉየሚገኝሌጆችሰሇራሳቸዉበሽታበቤተሰቦቻቸዉወይም
በተንከባካቢዎቻቸዉእንዯተነገራቸዉሇማወቅ፤ሇ/ 
ሰሇበሽታዉከመንገሩሂዯትጋርተያያዥነትጉዲዮችማጥናትናማወቅነዉ፡፡እርስዎምየዚህጥናትአካሌይሆኑዘነዴበትህትናእጠይ
ቅዎታሇዉጥናቱምሲጠናቀቅየተገኘዉንዉጥትሇሚመሇከታቸዉአካሊትበማቅረብሇህጻናትየሚዯረገዉንእንክብካቤሇማሻሻ
ሌጥረትአዯርጋሇሁ፡፡እንዱረደትየምፈሌገዉነገር፡ሀ/ከእርስዎየሚሰበሰበዉንመረጃሚስጥሮችሙለበሙለየሚጠበቅመሆኑ
ንሇ/የቃሇመጠይቅወረቀቱሊይስምዎትየማይሰፍርመሆኑን፤የምንጠቀመዉመሇያቁጥርብቻመሆኑንሐ/በጥናቱመሳተፍዎምን
ምአይነትጉዲትእንዯማስከትሌብዎመ/በመጨረሻምበጥናቱያሇመካፈሌመበትዎየተጠበቀመሆኑንይሆናሌጊዜዎንሇማካፈሌ
ዝግጁበመሆንዎበቅዴሚያአመሰግናሇሁ 
ስሇዚህፈቃዯኛከሆኑምሰክርነትዎንበቃሌእንዱሰጡኝእጠይቃሇሁ 
›­_____ ¾KU______ 
¾}dò¬eU“ò`T/¾×ƒ ›h^____________________________________ 
 
¾S[Í cwdu=¨<eU“ò`T______________________________________ 
የጥናቱባሇቤትስምናፊርማ : አቶሽመሌስነጋሽ_________________ 
አዴራሻስሌክ/ሞባይሌ -251911558363       ኢ.ሜሌ-shimels_1@yahoo.com 
SÖÃl ¾}VLuƒ k” ____________________________ 
¾S[Í Scwcu=Á pêlØ`__________________ 
የተሳታፊዉኮዴ_____________________ 
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Annex VI: አማርኛመጠይቅ 
ትዛዝ፡ ባድቦታዉንይሙለ፤ትክክሇኛዉንመሌስያክብቡ፤ምንምአይነትመረጃአትሇፉ 
ክፍሌአንዴአጠቃሊይጥያቄየቤተሰብ /ተንከባካቢበተመሇከተየሚሞሊ 
ተ.ቁ ጥያቄ አማራጭመሌስ ኮዴ 
101 መኖሪያአዴራሻ 1,ከተማ 
2,ገጠር 
 
102 ጾታ 1ወንዴ 
2 ሴት 
 
103 እዴሜ ______________________(ዓመት)  
104 ሃይማኖት 1,ኦርቶድክስ 
2,ሙስሉም 
3,ካቶሉክ 
4,ፕሮቴስታንት 
5, ሌሊ/ይገሇጽ______________________ 
 
105 የትምርትዯረጃ 1,ማንበብናመጻፍ  እማይችሌ 
2,ማንበብናመጻፍ የሚችሌ 
3,ያንዯኛ ዯረጃ(1-8) 
4,ሁሇተኛ ዯረጃ(9-12) 
5,ኮሌጅናከዚያ በሊይ 
 
106 የስራሁኔታ 1,የቤት እመቤት 
2,የመንግስት ሰራተኛ 
3,ገበሬ 
4,ነጋዳ 
5,የቀን/የጉሌበትስራተኛ 
6,ላሊ/ይገሇጽ________________ 
 
107 የጋብቻሁኔታ 1,,ያሊገባ/ች 
2,ያገባ/ች 
3,አግብቶ የፈታ/ች 
4,የሞተባት/የሞተችበት 
5,ላሊ/ይገሇጽ________________ 
 
108 የገቢሁኔታወርሃዊገቢበብር? ______________________ ብር  
ክፍሌሁሇት፡ የህጻኑን/ኗንሁኔታበተመሇከተየሚሞሊ 
201 ጾታ 1,ወንዴ 
2,ሴት 
 
202 እዴሜ _____________________(አመት)  
203 የትምህርትዯረጃ 1,ያሌጀመረ/ች 
2,መዋሇህጻናት 
3,የመጀመሪያ ዯረጃ(1-8) 
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4, ሁሇትኛዯረጃ(9-12) 
ክፍሌሦስት  :የወሊጅ/የተንከባካቢየጤናጋርየተገናኘጥያቄ 
301 የኤችአይ ቪ ምርመራአርገዉያዉቃለ? 1,አዎ 
2,አይ የሇም 
መሌሶ 2 ከሆነበቀጥታ 
ጥ.ቁ 305 ይሇፉ 
302 እባክዎንሰሇእርስዎኤችኤይ ቪ 
ሁንታሉነግርዎንይችሊለ ? 
1,አዎ 
2,አሌችሌም 
 
መሌሶ 2 ከሆነበቀጥታ 
ጥ.ቁ 305 ይሇፉ 
303 እሺካለየምርመራዎትንሁንታቢነገሩን? 1,ኤች አይ ቪ ፖዘቲቭ 
2,ኤች አይ ቪ ነጌቲቭ 
 
304 ፖዘቲቭከሆኑጸረኤችአይ ቪ 
መዴሀኒትይወሰዲለ? 
1,አዎን 
2,አሌወስዴም 
 
305 ሌጁ/ቷ 
በኤችአይቪምክንያትያጣዉ/ችዉቤተሰብአሇ ? 
1,አዎ 
2,አሊጣም/ችም 
መሌሶ 2 ከሆነበቀጥታ 
ጥ.ቁ 307 ይሇፉ 
306 አዎካለማንኛቸዉን ? 1,እናት 
2,አባት 
3,እናትናአባት 
4,ላሊ ቤተሰብካሇ 
 
307 ሌጁ/ቷ 
አሁንከማንጋርነዉየሚኖረዉ/የምትኖረዉ? 
1,ከእናትናከአባት ጋር 
2,ከዘመዴ ጋር 
3,ማሳዯጊያ ዴረጅትዉስጥ 
 
 
308 ሌጁ/ጅቷሇኤችአይ ቪ 
ህክምናክትትሌወዯክሉኒእንዯመጣያዉቃሌ?  
1,አዎ 
2,አይ አታቅም/ያቅም 
 
309 ሌጁ/ቷ ያሇባቸዉኤችአይ ቪ 
/በሽታስምያወቃሌ/ታዉቃሇች? 
1,አዎ 
2,አይ አያዉቅም /አታዉቅመ 
 
310 ሌጁ/ቷ 
የጸረኤችአይመዴሃኒትየሚወስደመሆናቸዉንያዉ
ቃለ? 
1,አዎ 
2,አያዉቅም /አታዉቅም 
 
311 ሇጁ/ጅቷኤችአይ ቪ እንዲሇባቸዉያወቃለወይ? 1,አዎ 
2,አይ አታዉቅም/አያዉቅም 
ከጥያቄ 308 -311 
ሇሁለምመሌሶች 2 
ከሆነበቀጥታጥ.ቁ 316 
ይሇፉ 
312 ከሊይካለትጥያቄ 308 – 3011 
አንደአዎከሆነሇሌጅ/ቷ ኤችአይ ቪ 
አንዲሇባቸዉየተነገራቸዉ/ያሳወቃቸዉማነዉ? 
1,ወሊጆች 
2,አያቶች 
3,ላሊ የቤተሰብአባሌ 
4,የጤና ባሇሙያ 
5,ላሊ ካሇይገሇጽ 
 
313 ሇሌጁ/ቷ ሰሇኤችአይ ቪ የተናገዉሰዉየኤችአይ 
ቪ ሁንታዉምንዴንነዉ? 
1,ኤች አይ ቪ ፖዘቲቭ 
2,ኤች አይ ቪ ኔጌቲቭ 
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3,አሊወቅም 
4,ሇመናገር ፈቃዯኛአይዯሇሁም 
314 ስሇበሽታዉ/ኤችአይ ቪ 
ሲነገረዉ/ራትእዴሜዉ/ዋ ስንትነበር? 
____________________________ አመት 
 
 
315 ሇሌጁ/ቷ ሰሇበሽታዉሇመንገርምክንያትምንነበር? 1,ሌጁ/ቷ እዴሜዉብቁመሆኑንበማሰብ 
2,ሇጁ/ቷ ህክምናዉንሇመከታተሌ 
/ክሉኒክበቀጠሮሰአትሇሜሄዴስሊሌሆነ/ች 
3,ከጓዯኞቹ/ቿ /ከጎረቤትስሇሰማ/ች 
4,ምን 
እንዯሆነ/እንዲጋጠመዉበተዯጋጋሚጥያቄበማንሳ
ቱ/ቷ 
5,ላሊ ምክንያት 
 
316 ሇሌጁ/ቷ ስሇበሽታዉ /ዋ 
ካሇተነገረዉ/ራትምክንያቱ? 
1,ሇጁ/ቷ አዴሜዉ/ዋ ስሊሌዯረሰ 
2,ሰሜታዊና 
የተሳሳተአመሇካከተሰሇጤናያሇዉንሇዉጦችበመ
ፍራት 
3,ሚስጢር  ሰሇማይጠበቅ/ትጠብቅ 
4,ቢነገረዉ/ራትሰሇማይገነዘቡ 
5,መናገር 
ወይምመግሇጽጥቅምእንዲሇዉባሇማወቅ 
6,ሌሊ ምክንያትካሇይገሇጽ 
 
317 ሌጁ/ቷ ስሇበሽታቸዉ /ኤችአይ ቪ 
/ሁኔታእማያወቁከሆኑሇምንወዯክሉኒክወይምመ
ዴሃኒቱንሇምንእነዯሚወስዴምንምክንያትይሰጣለ
?  
_____________________________________  
318 ሌጁ/ቷ 
ሇምንመዴሃኒትእንዯሚወስደጥያቄጠይቀዉአያ
ዉቁምወይ? 
1,አዎ 
2,አያዉቅም/አታወቅም 
 
319 አንዴሌጅሇኤችአይ ቪ መጋሇጡንመሳወቅ 
/መንገርጥቅምያሇዉይመሰሃሌ/ሻሌ?  
1,አዎ 
2,አይመስሇኝም 
3,አሊወቅም 
 
320 ወዯፊትሌጁሇኤችአይ ቪ 
መጋሇጡንሇማሳወቅ/ሇመናገርአሊማአሇህ/ሽ? 
1,አዎ 
2,አይ የሇኝም 
 
321 መሌስዎአዎከሆነየበሽታዉንሁኔታሇህጻኑ/ኗ 
በማንቢነገረዉ/ራትትመርጣሇህ /ትመርጫሇሺ? 
1,በራሴ /በእኔ 
2,በጤና ባሇሙያዋች 
3,በእኔናበጤናባሇሙያዎች 
 
322 ባንተ/ቺ 
አመሇካከትሌጆችመቼነዉየጤንነትሁኔታቸዉንወ
ይምሇኤችአይ ቪ መጋሇጣቸዉንማወቅያሇባቸዉ 
? 
1,በማነኛዉም ግዜናወቅት 
2,ሲያማቸዉ 
3,ጤንነት ሲሰማቸዉ 
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ክፍሌአራት፡መጠይቅየመዴሃኒትቁርኝትመገሇሌንናየአይምሮዴብርትንየተመሇከተሇወሊጆች/ሇአሳዲጊዎች 
401 ሌጁ/ቷ ጸረኤችአይ ቪ አሌወስዴምብሇዉአያዉኩመወይ? 1,አዎ 
2,አይ አያዉቅም/አታዉቅም 
 
402 መዴሃኒቱንሇሌጁ/ጅቷሳይሰጡትየቀረጊዜየሇምሰዉስሊሇሊሇመሰጠትፈሌገዉ? 1,አዎ 
2,አይ የሇም 
 
403 ችግርአጋጥምዎትአያወቅምየጸረኤችአይ ቪ መዴሃኒትአሌወሰዴምብሇዉምክንያቱመሌጁ/ቷ 
ኤችአይ ቪ እንዲሇበት/ባትስሇመያዉቅ/ታዉቅ? 
1,አዎ 
2,አይ የሇም 
 
404 ችገርአጋጥመዎትአያወቅመሇጁ/ቷ በሰአቱወይምበየቀኑጸረኤች ኤ ቪ 
መዴሃንቱንበሚሰጡዋቸዉገዜ? 
1,አዎ 
2,አይ የሇም 
 
405 ላልችሌጆችከሌጅዎጋርአንጫወትምብሇዉያዉቃለምክንያቱምሌጆኤችአይ ቪ ስሊሇባቸዉ? 1,አዎ 
2,አይ የሇም 
 
406 ላልችሌጆችሌጅዎትሊይይቀሌዴባቸዋሌወይምበኤችአይቪዉምክንያትበመጥፎይጠሩታሌ/ዋታሌ? 1,አዎ 
2,አይየሇም 
 
407 ሇጁ/ቷ በኤችአይ ቪ ምክንያትበጓዯኞቹ/ቿ ወይምበቤተሰብችሊይባሊለ? 1,አዎ 
2,አይ የሇም 
 
408 እንዯዉሇጁን/ጅቷንስመሇከተዋቸዉነገሮቸንበሚሰሩጊዜፍሇጎቱ/ቷ ወይምዯሰታዉ/ዋ  የቀነሰ/ች 
ይመስሌዎታሌ? 
1,አዎ 
2,አይ የሇም 
 
409 ሌጁ/ጅቷየመዯበትየመፈዘዝእናተስፋየመቁረጥስምትነበረዉ/ራት? 1,አዎ 
2,አይ የሇም 
 
5. secondary data Clinical markers of HIV infected children from ART record 
501 Age at diagnosis of HIV ______________________in years  
502 What is the current WHO clinical Stage? 1,T-Staging I 
2,T-Staging II 
3,T-Staging III 
4,T-Staging IV 
 
503 What is the child current CD4 count? __________________________  
504 What is the child Taking ART regimen? __________________________  
505 What is the child weight at baseline? _________________________(Kg)  
506 Dose the child has currently on Anti TB? 1,Yes 
2,No 
 
507 Dose the child has currently taking Co-trimoxzol? 1,Yes 
2,No 
 
 
ሇሰጡንምሊሽበጣምእናመሰግናሇን 
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